Connecting the Rutgers Research Community
May 19, 2020
.
|
|
|
Stay Connected:
Search for STEM Experts at Rutgers:
________________
THE CURIOUS CORNER
Who's more dangerous, the Asian Hornet or fear itself?
Photo: Quinlyn Baine, Washington State Department of Agriculture
How do you translate your curiosity into
ideas with us!
|
|
|
|
How Leaders in Academia, Industry and Students Came Together to Fill the PPE Gap on the COVID-19 Frontlines
by Marisol Seda
While 'necessity is the mother of invention,' the journey to an inspiring and extraordinary success could be enriched through collaboration and partnerships. This can be attested by Rutgers University and professional services company Accenture, which joined efforts towards the same goal: to solve the necessity of face shields and other personal protection equipment (PPE) for healthcare workers and researchers on the frontlines of the COVID-19 pandemic.
It started with that urgent need and an idea from Joseph Hanna, acute care surgeon and assistant professor at Robert Wood Johnson University Hospital, continued with a combination of passion, expertise and leadership, and has evolved into an organic 'operation bootstrap.' Almost serendipitously, the academia, the corporate world and the community conceived a business model similar to a startup. And now, the operation called RU 3D PPE project, has become an additional force fighting the spread of the deadly virus.
"Fifteen days it took, to go from an initial flurry of emails to the production of 180 sanitized and ready to use laser-cut face shields and 3D printed headbands through a network of 40 3D printers in facilities led by Rutgers Makerspace," said
Sacha Patera, associate vice president for Rutgers Corporate Engagement Center.
|
|
 |
| Sacha Patera, Rutgers Corporate Engagement Center |
|
|
|
|
| Kirtan Gandhi, Accenture |
|
|
|
|
| Jenna LaPietra, Accenture and Rutgers aluma |
|
|
|
|
|
|
|
|
Raymond B. Birge
|
|
Rutgers HealthAdvance
™
announces its inaugural award to advance the commercialization of anti-cancer therapeutics being developed by researchers Raymond B. Birge from New Jersey Medical School and William Welsh from Robert Wood Johnson Medical School, in collaboration with Youyi Peng at the Rutgers Cancer Institute of New Jersey. HealthAdvance provides up to $200,000 for a two-year period to support the development and de-risking of early-stage life sciences technologies with an impact on human health.
|
|
|
Youyi Peng
|
|
|
|
William Welsh
|
Guided by advanced in silico drug design tools, the research team will use the award for developing a series of first-in-class oncology drugs known as pan-TAM (Tyro3, Axl, Mertk) kinase inhibitors, expected to possess dual modes of action. First, the oncology drugs would work as anticancer agents that act directly on cancer cells to eliminate the tumors and prevent them from metastasizing. They would also work as Immune-Oncology (IO) agents that activate a patient's own adaptive immune system to attack and destroy cancer cells.
___________________________________________________________________________________
OARC COVID-19 Research Projects
The Office of Advanced Research Computing (OARC) team members and resources are involved in a number of emerging COVID-19 essential research projects.
OARC Associate Vice President, J. Barr von Oehsen, is among a team of Rutgers NJ ACTS Informatics leads working on a cross-institutional COVID-19 collaborative project.
The aim of the project is to leverage informatics to extract data for COVID-19 patients from electronic medical records and investigate risk factors and possible treatments for COVID-19 infection. The collaboration is led by NYU and spans across more than 12 large academic medical institutions in New York, New Jersey, and surrounding states. The Rutgers effort is led by Soko Setoguchi, who is coordinating the efforts of the NJ ACTS Informatics leads, Frank A. Sonnenberg, David J. Foran, and Barr von Oehsen, along with hospital IT experts from Robert Wood Johnson Barnabas Health.
___________________________________________________________________________________
Research System Training Available
Need to learn how to use the
Research Administration and Proposal Submission System (RAPSS) or the Effort Reporting system? You can find the schedules for these courses and register
online (under Business and Research Administration). Grant and Contract Accounting is also hosting a training session on Subaward Management. To register for this class, visit the
Cornerstone Course Registration under ORED - Grants & Contracts.
|
|
|
RESOURCES FOR RESEARCHERS
|
|
The core facility team at ORED has recently launched a grant program to provide
core facilities with support funding up to $100K. Applications will be accepted on a rolling basis until
December 31
and funding decisions will made on a rolling basis within 90 days of submission. All core facilities across all chancellor units at Rutgers are eligible. The
funding is expected to begin by July 1, 2020.
|
Cities around the world are taking meaningful action to advance health equity by designing solutions that benefit the health of people and our planet. Through this $3 million funding opportunity, the Robert Wood Johnson Foundation seeks to bring the most impactful ideas from across the globe to U.S. cities to address the intertwined issues of health, equity, and climate change. They are seeking proposals that foster learning and stimulate action in U.S. cities around smart, effective approaches from abroad that mitigate the unequal health risks posed by climate change. Specifically, they are seeking proposals that explore changes in city planning, policies, and programs that address: buildings and energy; land use and urban planning; transportation; waste; food systems and food security; and air quality.
Applications are due by May 28.
_______________________________________________________________________________
The Edward Mallinckrodt, Jr. Foundation is a private foundation that funds basic biomedical research throughout the United States. The mission of the Foundation is to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. Mallinckrodt Grants are usually $60,000 per year for three years, provided an annual progress report is submitted and approved. The proposal deadline is August 1. Rutgers is limited to submitting one candidate per cycle. Pre-proposals must be submitted through the Rutgers
Limited Submission process. Pre-proposals are due by
June 6.
_______________________________________________________________________________________________
The Busch Biomedical Grant program is designed to enhance biomedical research at the University and to strengthen the competitive position of faculty members who seek external research funds. The Busch Biomedical Grant Program is funded by the interest income from the Charles and Johanna Busch bequest to reflect the wishes of Charles Busch. The Busch Biomedical Grant program will support research projects up to a total of $40,000 for up to two years ($20,000 per year). Applicants must have a Full-Time Faculty appointment. The deadline has been extended to June 15.
|
Congratulations...
to the following researchers for their recently-awarded grants:
Norrinda Hayat - School of Law
Jason Yang
- New Jersey Medical School
Zhihua Kang - Cancer Institute of New Jersey
|
To view past issues of
Research Connections
, visit our
Archives
.
Copyright ©2020
, Rutgers University, an equal opportunity, affirmative action institution.
|
|
|
|
|
